Literature DB >> 7573125

Analysis of variability of clinical manifestations in Waardenburg syndrome.

J E Reynolds1, J M Meyer, B Landa, C A Stevens, K S Arnos, J Israel, M L Marazita, J Bodurtha, W E Nance, S R Diehl.   

Abstract

Expression of clinical findings of Waardenburg syndrome type 1 (WS1) and type 2 (WS2) is extremely variable. Using our collection of 26 WS1 and 8 WS2 families, we analyzed the occurrence, severity, and symmetry of clinical manifestations associated with WS. We found significant differences between WS1 and WS2 in deafness, and in pigmentary and craniofacial anomalies. Factor analysis was used to identify manifestations which covaried, resulting in 2 orthogonal factors. Since mean factor scores were found to differ when compared between WS1 and WS2, we suggest that these factors could be useful in distinguishing WS types. We found that the WS gene was transmitted from mothers more often than from fathers. We also extensively examined the W-Index, a continuous measure of dystopia canthorum. Our data suggest that use of the W-Index to discriminate between affected WS1 and WS2 individuals may be problematic since 1) ranges of W-Index scores of affected and unaffected individuals overlapped considerably within both WS1 and WS2, and 2) a considerable number of both affected and unaffected WS2 individuals exhibited W-index scores consistent with dystopia canthorum. Misclassification of families may have implications for risk assessment of deafness, since WS2 families have been reported to have greater incidence of deafness, as confirmed in our study.

Entities:  

Mesh:

Year:  1995        PMID: 7573125     DOI: 10.1002/ajmg.1320570405

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Major-locus contributions to variability of the craniofacial feature dystopia canthorum in Waardenburg syndrome.

Authors:  J E Reynolds; M L Marazita; J M Meyer; C A Stevens; L J Eaves; K S Arnos; L M Ploughman; C MacLean; W E Nance; S R Diehl
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

2.  Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2.

Authors:  Celia Zazo Seco; Luciana Serrão de Castro; Josephine W van Nierop; Matías Morín; Shalini Jhangiani; Eva J J Verver; Margit Schraders; Nadine Maiwald; Mieke Wesdorp; Hanka Venselaar; Liesbeth Spruijt; Jaap Oostrik; Jeroen Schoots; Jeroen van Reeuwijk; Stefan H Lelieveld; Patrick L M Huygen; María Insenser; Ronald J C Admiraal; Ronald J E Pennings; Lies H Hoefsloot; Alejandro Arias-Vásquez; Joep de Ligt; Helger G Yntema; Joop H Jansen; Donna M Muzny; Gerwin Huls; Michelle M van Rossum; James R Lupski; Miguel Angel Moreno-Pelayo; Henricus P M Kunst; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2015-10-29       Impact factor: 11.025

3.  Targeted next-generation sequencing identified a novel variant of SOX10 in a Chinese family with Waardenburg syndrome type 2.

Authors:  Xiao-Wen Liu; Su-Yang Wang; Zhan-Kui Xing; Yi-Ming Zhu; Wen-Juan Ding; Lei Duan; Xiao Cui; Bai-Cheng Xu; Shu-Juan Li; Yu-Fen Guo
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

4.  Clinical manifestations of Waardenburg syndrome in a male adolescent in Mali, West Africa.

Authors:  Pascal James Imperato; Gavin H Imperato
Journal:  J Community Health       Date:  2015-02

5.  The Hearing Outcomes of Cochlear Implantation in Waardenburg Syndrome.

Authors:  Hajime Koyama; Akinori Kashio; Aki Sakata; Katsuhiro Tsutsumiuchi; Yu Matsumoto; Shotaro Karino; Akinobu Kakigi; Shinichi Iwasaki; Tatsuya Yamasoba
Journal:  Biomed Res Int       Date:  2016-06-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.